Literature DB >> 12244480

Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans.

Benito Casu1, Annamaria Naggi, Giangiacomo Torri.   

Abstract

Sulfated glycosaminoglycans (GAGs) are amenable to a number of chemical modifications that modulate their biological activity. N-sulfate groups can be exposed and N-acylated (usually N-acetylated), specific O-sulfate groups can be removed, and free hydroxyl groups (either preexisting in the original GAG or exposed by desulfation) can be sulfated. Heparin/heparan sulfate, chondroitin sulfate, and dermatan sulfate have been variously desulfated or sulfated to afford novel GAGs with protein binding and associated biological properties different from those of the original GAGs. Regiospecific sulfation of N-acetyl heparosan ( E. coli K5 polysaccharide) afforded a number of derivatives, some endowed with antithrombotic activity and others with antimetastatic properties. Most of the activities could be correlated with typical sulfation patterns along each GAG backbone. Glycol splitting of nonsulfated glucuronic residues (including a critical residue in the pentasaccharide sequence of the active site for antithrombin) leads to substantial loss of anticoagulant activity of heparin. Partial removal of sulfate groups at position 2 of iduronic acid residues followed by glycol splitting of all nonsulfated uronic acid residues afforded nonanticoagulant, antiangiogenic heparins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244480     DOI: 10.1055/s-2002-34302

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  8 in total

Review 1.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

2.  Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.

Authors:  Maura Poli; Michela Asperti; Annamaria Naggi; Natascia Campostrini; Domenico Girelli; Michela Corbella; Marina Benzi; Celine Besson-Fournier; Helene Coppin; Federica Maccarinelli; Dario Finazzi; Paolo Arosio
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

3.  Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Glycobiol Insights       Date:  2010-02-02

4.  Structure/function analysis of Pasteurella multocida heparosan synthases: toward defining enzyme specificity and engineering novel catalysts.

Authors:  Nigel J Otto; Dixy E Green; Sayaka Masuko; Alain Mayer; Martin E Tanner; Robert J Linhardt; Paul L DeAngelis
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

5.  Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin.

Authors:  Ditmer T Talsma; Kirankumar Katta; Miriam Boersema; Saritha Adepu; Annamaria Naggi; Giangiacomo Torri; Coen Stegeman; Gerjan Navis; Harry van Goor; Jan-Luuk Hillebrands; Saleh Yazdani; Jacob van den Born
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

6.  Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis.

Authors:  Pragyi Shrestha; Kirankumar Katta; Ditmer Talsma; Annamaria Naggi; Jan-Luuk Hillebrands; Bart van de Sluis; Jacob van den Born
Journal:  Front Cell Dev Biol       Date:  2022-03-07

Review 7.  Hepcidin antagonists for potential treatments of disorders with hepcidin excess.

Authors:  Maura Poli; Michela Asperti; Paola Ruzzenenti; Maria Regoni; Paolo Arosio
Journal:  Front Pharmacol       Date:  2014-04-28       Impact factor: 5.810

Review 8.  Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections.

Authors:  Daniel P Otto; Melgardt M de Villiers
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.